Latest Pharmaceutical manufacturing News

An employee of SinoVac works in a lab at a factory producing its SARS CoV-2 Vaccine for COVID-19 named CoronaVac in Beijing on Thursday, Sept. 24, 2020. SinoVac's CEO says they have injected 90 percent of its employees and family members, or about 3,000 people, and provided tens of thousands of rounds of CoronaVac to the municipal government of Beijing. It's a highly unusual move that raises ethical and safety questions, as companies and governments worldwide race to develop a vaccine that will stop the spread of the new coronavirus. (AP Photo/Ng Han Guan)

China pushes emergency use of COVID vaccine despite concerns

Sep. 26, 2020 6:58 AM EDT

BEIJING (AP) — After the first shot, he had no reaction. But Kan Chai felt woozy following the second dose of a COVID-19 vaccine approved for emergency use in China. “When I was driving on the road, I suddenly felt a bit dizzy, as if I was driving drunk," the popular writer and columnist recounted...

President Donald Trump signs an executive order after delivering remarks on healthcare at Charlotte Douglas International Airport, Thursday, Sept. 24, 2020, in Charlotte, N.C. (AP Photo/Chris Carlson)

Trump's $200 prescription cards won't hit mailboxes just yet

Sep. 26, 2020 12:48 AM EDT

WASHINGTON (AP) — If you’re on Medicare, don’t run to the mailbox looking for a $200 prescription drug card courtesy of President Donald Trump. Government officials said Friday that key details of Trump's election-year giveaway still have to be fleshed out, including the exact timing and how...

FILE - In this July 22, 2020, file photo, Tyson Salomon, left, gets a pedicure outside Pampered Hands nail salon in Los Angeles. A steady drop in coronavirus cases across California cleared the way Tuesday, Sept. 22, 2020, for the wider reopening of businesses in nine counties, including much of the San Francisco Bay Area, the state's top health official said. Dr. Mark Ghaly, the state health secretary, said nail salons could also reopen with restrictions, though he cautioned that California's reopening must remain

The Latest: Concerns over coronavirus upticks in California

Sep. 25, 2020 9:38 PM EDT

SACRAMENTO, Calif. -- California has begun to see concerning upticks in coronavirus data after a period of decline. The state health secretary said Friday that there have been increases in the number of newly confirmed cases, hospital emergency department visits for COVID-19 and new hospitalizations for...

Novavax, Endo rise; Cavco, Occidental Petroleum fall

Sep. 25, 2020 6:52 PM EDT

NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday: Novavax Inc., up $11.12 to $113.56. The biotechnology company started a key study in the United Kingdom for a potential COVID-19 vaccine. Colony Capital Inc., up 29 cents to $2.63. The real estate investment firm is selling some of...

A woman looks at screens showing Japan's Nikkei 225 index at a securities firm in Tokyo on Friday, Sept. 25, 2020. Asian shares advanced Friday, cheered by a modest rally on Wall Street and rising hopes for fresh stimulus for the U.S. economy.(AP Photo/Hiro Komae)

Stocks post solid gains as technology shares lead rally

Sep. 25, 2020 6:27 PM EDT

Stocks shook off another bout of volatile trading and finished solidly higher Friday, led by gains in technology and health care companies. Despite the rally, the S&P 500 still posted its fourth straight weekly loss, extending Wall Street's September swoon. The S&P 500 rose 1.6% after flip-flopping...

People board a bus outside Waterloo station in London, Wednesday, Sept. 23, 2020, after Prime Minister Boris Johnson announced a range of new restrictions to combat the rise in coronavirus cases in England, Wednesday, Sept. 23, 2020. (Dominic Lipinski/PA via AP)

Drugmaker Novavax begins late-stage vaccine trial in UK

Sep. 25, 2020 8:38 AM EDT

LONDON (AP) — U.S.-based Novavax has begun a late stage trial of its potential COVID-19 vaccine in the United Kingdom because the high-level of the coronavirus circulating in the country is likely to produce quick results, the pharmaceutical company said. Novavax plans to test the effectiveness of its...

Zheng Zhongwei, an official with China's National Health Commission, holds a chart showing different priority groups for a coronavirus vaccine as he speaks during a press conference held to discuss COVID-19 vaccine-related issues at the State Council Information Office in Beijing, Friday, Sept. 25, 2020. A Chinese health official said Friday that the country's annual production capacity for COVID-19 vaccines will top 1-billion next year, following an aggressive government support program for new factories. (AP Photo/Mark Schiefelbein)

China aims to make 1 billion COVID-19 vaccine doses a year

Sep. 25, 2020 7:21 AM EDT

BEIJING (AP) — A Chinese health official said Friday that the country's annual production capacity for coronavirus vaccines will top 1 billion doses next year, following an aggressive government support program for construction of new factories. Capacity is expected to reach 610 million doses by the end of...

Flower vendors wait for buyers at a wholesale market in Bengaluru, India, Thursday, Sept. 24, 2020. The nation of 1.3 billion people is expected to become the COVID-19 pandemic's worst-hit country within weeks, surpassing the United States. (AP Photo/Aijaz Rahi)

The Latest: $14M more in virus funds for 3 Ariz universities

Sep. 24, 2020 9:23 PM EDT

PHOENIX — Arizona will provide the state’s three public universities with $14 million in additional funding to boost their efforts to test, track and respond to the coronavirus. Gov. Doug Ducey said Thursday the money will help the universities build on their current efforts to track and contain...

Yin Weidong, CEO of the Chinese pharmaceutical company SinoVac, speaks to journalists during a tour of a vaccine factory in Beijing on Thursday, Sept. 24, 2020. SinoVac, one of China's pharmaceutical companies behind a leading COVID-19 vaccine candidate says its vaccine will be ready by early 2021 for distribution worldwide, including the U.S. (AP Photo/Ng Han Guan)

Chinese company says coronavirus vaccine ready by early 2021

Sep. 24, 2020 9:15 PM EDT

BEIJING (AP) — A Chinese pharmaceutical company said Thursday the coronavirus vaccine it is developing should be ready by early 2021 for distribution worldwide, including the United States. Yin Weidong, the CEO of SinoVac, vowed to apply to the U.S. Food and Drug Administration to sell CoronaVac in the...

FILE - In this Tuesday, May 13, 2014 file photo, AstraZeneca CEO Pascal Soriot leaves the British Parliament's Business Innovation and Skills Committee after a hearing in central London. Two firms developing COVID-19 vaccines say pharmaceutical companies are trying to give the public as much information as possible about their testing regimes as drugmakers and public health officials seek to boost confidence that any approved vaccine will be safe. AstraZeneca CEO Pascal Soriot and Paul Stoffels, chief scientific officer of Johnson & Johnson, said Thursday Sept. 24, 2020, that they recognize the coronavirus emergency demands increased transparency from vaccine developers to ensure the public has faith in the end product. (AP Photo/Lefteris Pitarakis, File)

Drug companies work jointly to boost vaccine confidence

Sep. 24, 2020 7:32 AM EDT

LONDON (AP) — Two firms developing COVID-19 vaccines say pharmaceutical companies are trying to give the public as much information as possible about their testing regimes as drugmakers and public health officials seek to boost confidence that any approved vaccine will be safe. AstraZeneca CEO Pascal...